News

ChromaDex's Yasmeen Nkrumah-Elie Wins Trailblazing Woman Award

ChromaDex's Yasmeen Nkrumah-Elie Wins Trailblazing Woman Award

Yasmeen Nkrumah-Elie Recognized for Her Impact in Nutrition

ChromaDex Corp. (NASDAQ:CDXC), a leader in nicotinamide adenine dinucleotide (NAD+) research, has announced a significant achievement recognized by industry peers. Yasmeen Nkrumah-Elie, Ph.D., serves as the company’s Global Director of External Research and has recently received the prestigious Trailblazing Woman Award from Radicle Science and the Council for Responsible Nutrition.

The Importance of the Trailblazing Woman Award

The Trailblazing Woman Award celebrates exceptional women who have made profound contributions to the dietary supplement and functional food industries. Dr. Nkrumah-Elie's distinguished career has been marked by her unwavering commitment to scientific advancement, her advocacy for diversity, and her mentorship of aspiring female leaders in the field.

A Message from Dr. Nkrumah-Elie

Upon receiving this honor, Dr. Nkrumah-Elie expressed her heartfelt gratitude, stating, "I am deeply honored to receive the Trailblazing Woman Award. The inspiring women in our industry demonstrate how we can push boundaries together. I am proud to play a role in a sector dedicated to enhancing wellness and global health." Her words reflect the collaborative spirit that drives progress in nutrition science.

Commitment to Advancing Science

In her pivotal role at ChromaDex, Dr. Nkrumah-Elie engages deeply with various scientific and regulatory bodies. She is an active member of the Senior Scientific Advisory Council of CRN and works tirelessly with organizations like Women In Nutraceuticals (WIN) and the American Society for Nutrition. Through speaking engagements and collaborations, she bridges scientific knowledge with public understanding, enhancing nutritional literacy.

Achievements of ChromaDex's External Research Program

Dr. Nkrumah-Elie has adeptly led the ChromaDex External Research Program (CERP), transforming it into an acclaimed initiative that engages in nearly 300 research collaborations globally. Under her direction, CERP has cultivated over 30 published clinical trials and identified numerous intellectual property opportunities, reinforcing its position as a benchmark for industry-academia collaboration.

Industry Recognition

Industry leaders have commended Dr. Nkrumah-Elie's contributions. Andrew Shao, Ph.D., Senior Vice President at ChromaDex, noted the evolution of CERP under her guidance, emphasizing how her leadership has set new standards for research quality and partnerships. Pelin Thorogood, Co-Founder of Radicle Science, highlighted her multifaceted impact beyond mere research, alluding to her role as a mentor and advocate for women in science.

About ChromaDex and Its Mission

ChromaDex Corp. stands as a pillar in advancing the science of healthy aging through NAD+ research. Their dedication is evident in their flagship product, Niagen, a patented nicotinamide riboside. Niagen's efficiency as a NAD+ booster has made it the top choice in the healthy aging supplement market. As people age, maintaining adequate NAD+ levels is crucial for preserving health and vitality.

By adhering to rigorous scientific and safety standards, ChromaDex demonstrates its commitment to transparency and quality in the development of nutritional supplements. They work alongside esteemed research institutions to maximize the benefits of NAD+ for consumers.

Consumer Reach and Future Innovations

Tru Niagen, the consumer-facing brand of Niagen, has become a leading choice in the United States for individuals seeking to improve their health as they age. As a testament to its effectiveness, the product is backed by clinical studies that substantiate its ability to enhance NAD+ levels.

Frequently Asked Questions

Who is Yasmeen Nkrumah-Elie?

Yasmeen Nkrumah-Elie, Ph.D., is the Global Director of External Research at ChromaDex and has been recognized for her contributions to the dietary supplement industry.

What is the Trailblazing Woman Award?

This award honors women who have made exceptional impacts in the dietary supplement and functional food industries, highlighting their leadership and innovation.

What is ChromaDex known for?

ChromaDex is known for its research on nicotinamide adenine dinucleotide (NAD+) and its clinically proven ingredient, Niagen.

What role does Dr. Nkrumah-Elie play at ChromaDex?

She leads the External Research Program and fosters collaborations with various scientific organizations to advance research in nutrition.

Why is NAD+ important for health?

NAD+ is a vital coenzyme found in all human cells. Its levels decline with age, and maintaining adequate NAD+ is essential for supporting overall health and vitality.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Growing Need for Postmortem Brain Tissue in Autism Research

Updated Category News Views 61

Increasing Demand for Autism BrainNet Resources Over recent years, there has been a notable rise in the demand for postmortem brain tissue resources provided by Autism BrainNet. Since its inception in 2014 under the Simons Foundation, the organization has significantly increased its collection of brain donations aimed at advancing autism research. The importance of these...

Continue Reading
The Remarkable Journey of FirstCash Holdings Over Two Decades

Updated Category News Views 57

Exploring the Growth of FirstCash Holdings Stock Investors seeking solid long-term returns often look to FirstCash Holdings (NASDAQ: FCFS) as a prime example. Over the last two decades, this company has consistently outperformed the market, boasting an average annual return of 11.88%, surpassing the market by 3.34% annually. Today, FirstCash Holdings stands tall with a...

Continue Reading
Cometa Energía and Tierra Mojada Launch Cash Tender Offers

Updated Category News Views 428

Cometa Energía and Tierra Mojada Begin Cash Tender Offers This announcement pertains to offers for securities issued by Cometa Energía, S.A. de C.V. and Tierra Mojada Luxembourg II S.à r.l. Cometa Energía, S.A. de C.V., a variable capital corporation organized under the laws of Mexico, and Tierra Mojada Luxembourg II S.à r.l., a private limited liability company...

Continue Reading
Anticipating Krystal Biotech's Upcoming Earnings Report

Updated Category News Views 127

Upcoming Earnings Report for Krystal Biotech Krystal Biotech KRYS is preparing to announce its quarterly earnings report. As anticipation builds, it's crucial for investors to stay informed about what to expect as the announcement draws near. Analyst Earnings Estimates Analysts project that Krystal Biotech will declare an earnings per share (EPS) of $1.29. Shareholders...

Continue Reading
Barbara Corcoran's Key Traits for Entrepreneurial Success

Updated Category News Views 408

Identifying Key Entrepreneurial Traits Barbara Corcoran, a renowned real estate investor and a key figure on "Shark Tank," has navigated countless deals with budding entrepreneurs. Over the years, she has developed insights into what separates successful businesses from those that falter. Beyond the business model, Corcoran is keenly focused on the qualities of the...

Continue Reading